Researchers have devised a potential drug regimen for tuberculosis that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.
Researchers have devised a potential drug regimen for tuberculosis that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.